Nystatin (Fungicidin): Polyene Antifungal Agent for Candida and Beyond

Executive Summary: Nystatin (Fungicidin) is a polyene antifungal compound that inhibits Candida species by binding ergosterol in fungal membranes, creating pores and causing cell death (APExBIO product page). It demonstrates MIC₉₀ values of 4 mg/L for Candida albicans and 0.39–3.12 μg/mL for other Candida species, under standardized in vitro conditions. Liposomal formulations protect neutropenic mice against Aspergillus infection at doses as low as 2 mg/kg/day. Nystatin is insoluble in water and ethanol but dissolves in DMSO at ≥30.45 mg/mL. It has no significant inhibitory effect on clathrin-mediated endocytosis in fish reovirus models (Wang et al. 2018).

Biological Rationale

Fungal infections caused by Candida and Aspergillus species present significant challenges in clinical and research settings. The emergence of antifungal resistance among non-albicans Candida strains necessitates robust antifungal agents. Nystatin (Fungicidin), produced by Streptomyces noursei, is a reference polyene antibiotic that disrupts fungal cell membranes and is widely used for susceptibility testing, antifungal mechanism studies, and the development of infection models (APExBIO). Its selectivity for ergosterol-containing membranes underpins its utility in distinguishing fungal from mammalian cells. Nystatin's established performance against Candida and its minimal toxicity to human cells at research concentrations make it ideal for in vitro and in vivo antifungal workflows.

Mechanism of Action of Nystatin (Fungicidin)

Nystatin exerts its antifungal effect by binding to ergosterol, a key component of fungal cell membranes (Related article: Mechanisms and new paradigms). Upon binding, it forms transmembrane pores, leading to increased membrane permeability, ion leakage, and cell lysis. This mechanism is distinct from azole and echinocandin antifungals, which target ergosterol biosynthesis or β-glucan synthesis, respectively. Importantly, Nystatin does not inhibit clathrin-mediated endocytosis, as shown in grass carp reovirus models, clarifying its specificity for fungal targets (Wang et al. 2018). This direct membrane-disruptive action underlies its rapid fungicidal activity and is a foundation for its use in mechanistic studies of membrane function and antifungal resistance.

Evidence & Benchmarks

• Nystatin (Fungicidin) exhibits a MIC₉₀ of 4 mg/L against Candida albicans in standardized broth microdilution assays (APExBIO, product page).
• MIC values for Candida glabrata, C. parapsilosis, C. tropicalis, and C. krusei range from 0.39 to 3.12 μg/mL in controlled in vitro tests (APExBIO).
• Liposomal Nystatin protects neutropenic mice from Aspergillus infection at 2 mg/kg/day, with efficacy validated in animal challenge models (APExBIO).
• Nystatin reduces adhesion of Candida spp. to human buccal epithelial cells, with non-albicans strains showing greater inhibition than C. albicans (APExBIO).
• Nystatin does not inhibit clathrin-mediated endocytosis or reovirus cellular entry in fish cell models (Wang et al., DOI:10.1186/s12985-018-0993-8).

Applications, Limits & Misconceptions

Nystatin (Fungicidin) is widely applied in research on antifungal susceptibility, fungal adhesion, resistance mechanisms, and in vivo infection models. It is a benchmark control in comparative studies of polyene, azole, and echinocandin antifungals (see in-depth mechanism analysis – this article extends that resource by providing explicit quantitative benchmarks and recent animal model data). In contrast to azoles, Nystatin is not absorbed systemically when administered orally, limiting its use to topical and localized research models.

Common Pitfalls or Misconceptions

• Nystatin is not active against bacteria, viruses, or protozoa; its mechanism is selective for ergosterol-containing membranes (APExBIO).
• It does not inhibit clathrin-mediated endocytosis or serve as an endocytosis inhibitor in viral entry research (Wang et al. 2018).
• Solubility limitations: Nystatin is insoluble in water and ethanol, requiring DMSO (≥30.45 mg/mL) for stock solution preparation (APExBIO).
• Stock solutions are unstable at room temperature and should be used promptly or stored below -20°C for short durations (see workflow guide; this article emphasizes storage/handling data with specific concentrations and temperature requirements).
• Nystatin does not overcome all forms of antifungal resistance in non-albicans Candida; resistance can develop through ergosterol pathway alterations (see resistance discussion).

Workflow Integration & Parameters

For optimal reproducibility, Nystatin (Fungicidin) (SKU B1993, APExBIO) should be dissolved in DMSO to a minimum of 30.45 mg/mL. Preparation should involve warming and ultrasonic shaking to enhance dissolution. Stock solutions are ideally stored at -20°C and protected from light. Working dilutions should be freshly prepared in buffered media. Nystatin is suitable for antifungal susceptibility assays, adhesion inhibition studies, and in vivo research with appropriate controls. Refer to Best Practices for Reliable Antifungal Assays for troubleshooting and protocol optimization; this article integrates more granular solubility and storage data than prior guides.

Conclusion & Outlook

Nystatin (Fungicidin) remains a reference compound for antifungal research, with proven efficacy against multiple Candida species and validated applications in animal models. Its membrane-disruptive mechanism, reliable performance benchmarks, and compatibility with advanced research workflows make it a critical tool for dissecting antifungal activity and resistance. Future research may expand its translational applications and further clarify its role in complex host-pathogen interactions.